Piekos Brian
SEC insider (Form 3/4/5 filer). CIK 0001815308. Chief Financial Officer at KalVista Pharmaceuticals, Inc. (KALV). 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in FRAMINGHAM, MA.
Companies Piekos Brian has filed insider reports for
- KalVista Pharmaceuticals, Inc. (KALV): Officer, Chief Financial Officer
Piekos Brian
CIK: 0001815308
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KalVista Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirect21.7K shares- - May 22, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1.5K shares at avg. $26.78$40K - May 21, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect5K shares- - Apr 17, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1.9K shares at avg. $20.22$38K - Apr 16, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect6.3K shares- - Feb 23, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1.8K shares at avg. $15.57$28K - Feb 21, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect5K shares- - Jan 16, 2026KALV
KalVista Pharmaceuticals, Inc.
AwardDirectRestricted Stock Unit
100K shares- - Nov 24, 2025KALV
KalVista Pharmaceuticals, Inc.
SaleDirect4.5K shares at avg. $13.45$60K - Nov 21, 2025KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | Disposition | 21,661 | - | $0 | Direct |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,489 | $26.78 | $39,882 | Direct |
| May 21, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 5,000 | - | $0 | Direct |
| Apr 17, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,862 | $20.22 | $37,643 | Direct |
| Apr 16, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 6,250 | - | $0 | Direct |
| Feb 23, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,767 | $15.57 | $27,507 | Direct |
| Feb 21, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 5,000 | - | $0 | Direct |
| Jan 16, 2026 | KALV KalVista Pharmaceuticals, Inc. | Award Restricted Stock Unit | 100,000 | - | - | Direct |
| Nov 24, 2025 | KALV KalVista Pharmaceuticals, Inc. | Sale | 4,471 | $13.45 | $60,139 | Direct |
| Nov 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 15,000 | - | - | Direct |
1-10 of 12 transactions